ARTIGO ORIGINAL
/ ORIGINAL
ARTICLE
EFFICACYOFABSOLUTE
ALCOHOLINJECTION
COMPAREDWITHBAND
LIGATIONINTHEERADICATION
OFESOPHAGEALVARICES
AngeloPauloFERRARI,GustavoAndradedePAULO,
ClaudiaMariaFerreiradeMACEDO,IsabelaARAÚJOandErmelindoDELLALIBERAJr.
ABSTRACT-Background-Endoscopicsclerotherapyisanabsoluteindicationfortreatingesophagealvarices.Re-bleedingis commonduringthetreatmentperiod,beforeallvaricesbecomeeradicated.Aim-Tocomparetwotechniquesofendoscopic esophagealvariceseradication:sclerotherapywithabsolutealcoholandbandingligation.PatientsandMethod-Forty-six patientswithlivercirrhosisandesophagealvariceswereprospectivelyrandomizedintotwotreatmentgroups:endoscopic sclerotherapywithabsolutealcoholandbandingligation.Patientswereincludediftheyhadlargevariceswithsignsofhigh bleedingrisk.InformedwritingconsentwasobtainedfromeverypatientandtheEthicsCommitteeofFederalUniversityof SãoPaulo,SP,Brazil,approvedthestudy.Aftereradication,allpatientswerefollowedupto1yeartolookforre-bleeding episodesandvaricealrecurrence.Results-Bothgroupsweresimilarexceptthatmalegenderwasmorecommoninthe sclerotherapygroup.Therewasnostatisticaldifferenceregardingvaricealeradication(78.3%insclerotherapygroupvs 73.9%intheligationgroup),recurrence(26.7%vs42.9%,respectively)anddeathrelatedtoanycause(21.7%vs13.9%). Inthesclerotherapygroupmoresessionswereneedtoobtaincompletevaricealeradication.Inthisgroupwedidobserve ahighre-bleedingrate(34.8%)andmoreulcersassociatedwithretrosternalpainrightaftertheprocedure.Therewasno differenceregardingoverallmorbidityandmortality.Conclusions-Bandingligationrequiresfewersessionsthansclerotherapy withabsolutealcoholtoeradicateesophagealvarices.Bothmethodsareequallyefficientregardingvaricealeradicationand recurrenceduringashortfollow-upperiod.
HEADINGS–Esophagealandgastricvarices,therapy,Sclerotherapy.Ligation.Hypertension,portal.Gastrointestinalhemorrhage.
INTRODUCTION
Cirrhosisisacommoncauseofportalhypertension and esophageal varices (EV) are present in 30% to 40%ofpatientswithcompensateddisease(noascites, encephalopathyorseverejaundice)andupto60%with decompensateddisease(4, 18, 23).Itisestimatedthatthe
annualincidenceofvaricesincirrhoticpatientsvaries between5%and20%(18).
GastrointestinalbleedingcausedbyEVruptureisa majorclinicalcomplicationandoccursinupto30%of patientswithchronicliverdisease(38).Mortalityassociated
tothefirstbleedingepisoderangesbetween30%and 50%(18).Ifuntreated,60%ofpatientswhosurvivethe
firstbleedingepisodewillrebleed(7).
Endoscopicsclerotherapy(ES)hasbeenwidelyused inthetreatmentofEV(21).Absolutealcoholinjection
requiresshortertimetoeradicatevariceswhencompared
to5%ethanolamineoleate(30),withsimilarrebleeding
andcomplicationrates.
Bandligation(BL)ofvariceswasfirstreportedbyVan STIEGMANNetal.(39).Currentlyitisconsideredthetreatment
ofchoiceinthepreventionofrebleeding(5,9,18,34,36).
AlthoughBLisconsideredthegoldstandardinthe eradicationofvarices,ESisstillwidelyusedbecause itisaneasyandcheaptechnique,withprovenefficacy. Among available sclerosants, absolute alcohol is the cheapest.The aim of this prospective study was to comparetheresultsofESwithabsolutealcoholandBL inthetreatmentofEVincirrhoticpatients.
PATIENTSANDMETHOD
Thisrandomizedprospectivestudywasconductedat theDivisionofGastroenterologyofFederalUniversity
ofSãoPaulo(“EscolaPaulistadeMedicina–UNIFESP-DivisionofGastroenterology–FederalUniversityofSãoPaulo,SãoPaulo,SP,Brazil
FerrariAP,PauloGA,MacedoCMF,AraújoI,DellaLiberaJrE.Efficacyofabsolutealcoholinjectioncomparedwithbandligationintheeradicationofesophagealvarices
EPM”,SãoPaulo,SP,Brazil)andwasapprovedbytheEthics CommitteeofthisUniversity.
BetweenNovember1998andAugust2001,cirrhoticpatientswith EVrequiringtreatmentwererandomized(usingclosedenvelopes) intotwogroups:ESwithabsolutealcoholandBL.
Inclusion criteria were: patients older than 18 years with portalhypertensionduetocirrhosis,withmediumorlargesize EV,historyofvaricealbleedingorhigh-riskofbleeding(medium orlargesizevariceswithred-spots),whohadundergoneless thantwoprevioussessionsofESorBLperformedduringan acutebleedingepisode.
Patients who did not agree with this study, with portal hypertension due to schistosomiasis, currently under pharmacologicaltreatmentorwithprevioussurgicaltreatment forportalhypertension,withsevereclinicaldiseasesassociated to the chronic liver disease preventing follow-up (1 year), pregnantorbreast-feedingwomen,wereexcluded.
Diagnosisofchronicliverdiseasewasestablishedthroughmedical history,physicalexamination,abdominalultra-soundandliver functionbloodtests.Liverbiopsywaseventuallyperformed.Patients weregradedaccordingtotheChild-Pughclassification(3).
Duringendoscopy,thenumberandsizeofvaricesandthe presenceorabsenceofred-spotswererecorded.Varicealsizeswere gradedassmall(straightvaricesthatdisappearwithinsufflation), medium(tortuousvaricesslightlydeformedbyinsufflation)or large(tortuousvaricesnotdeformedbyinsufflation).
Thepresenceofesophagealulcers(withorwithoutbleeding), variceal hemorrhage during the study period (re-bleeding), stenosis and esophageal perforation were considered major complications.Minorcomplicationsincludedretrosternalpain and dysphagia. X-rays or any other exams were performed whenevernecessary.
Patientswerefollowed-upfor1yearaftercompleteeradication, withendoscopicexaminationsat3,6and12months.
Endoscopieswereperformedunderconscioussedationevery 7-10daysuntilvaricealeradication.Proceedingswereeventually postponedinthepresenceofulcerssecondarytotreatment.Varices wereconsiderederadicatedaftercompletedisappearance.
IntheESgroup0.5to1.0mLofabsolutealcoholwasinjected intoeachvarix(maximum4mLpersession).Injectionswere performedclosetothecardiaandallvaricesweretreatedinthe samesessionwheneverpossible.
In the BL group multiple band kits were used following usualtechnique.Uptosixbandswereplacedineachsession. Ligationstartedclosetothecardiaandallvariceswereligated inthesamesessionwheneverfeasible.
Threeend-pointswerecomparedbetweenthetwogroups: varicealeradication,complicationsandrecurrence.Somefactors associatedtotheseend-pointsweretakenintoaccount:age, gender,etiologyofliverdisease,hepaticfunctionaccordingto Child-Pughclassification,primaryorsecondaryprophylaxis, presence or absence of red-spots, number of sessions and techniqueused.Significanceofqualitativedatawasestablished usingtheChi-square(χ2)testorFisherexacttest.Quantitative
variableswerecomparedbyusingStudentttest.Significance leveladoptedwas5%(α=0.05).
RESULTS
Forty-sixpatientswereincludedandrandomized,23ineach group.Table1showsthecharacteristicsofbothgroups.
Therewasamalepredominanceinbothgroupsalthough thereweremorewomenintheBLgroupthanintheESgroup (P=0.03).Althoughsomepatientshadmorethanoneetiology, alcoholandviruswerethemostfrequent.Patientsweregraded as Child B (47.8%), ChildA (37%) and Child C (15.2%). Twenty-fivepatients(54.3%)hadnohistoryofvaricealbleeding (primaryprophylaxis).Noneofthesesfactorsreachedstatistically significantdifference.
IntheESgroup18/23(78.3%)hadtheirvariceseradicated. Twopatientsabandonedtreatmentbeforeeradicationandthree diedbeforefinishingthetreatment.Meannumberofsessions was 4.7 ± 3.0. In the BL group eradication was achieved in 17/23 patients (73.9%). Four patients did not complete treatment and other two died before the end of the study. Meannumberofeffectivesessionswas2.9±2.0.
Ingeneral,1.8±0.8moresessionswerenecessaryinthe ESgroupcomparedwithBLgroup(P=0.02;IC95%:0.28 –3.37).Nodifferencewasfoundregardingoverallsuccessrate ineradicatingvaricesinbothgroups(Table2).
IntheESgroup,18patientsthatachievederadicationwere followeduptoverifyrecurrence.Onepatientabandonedthe studyandtwootherdied.Amongthe15patientsstudiedat 1yearaftereradication,4(26.7%)hadvaricealrecurrence. IntheBLgroup,17patientsthathadtheirvariceseradicated
TABLE1–Patients’characteristicsinbothgroups.Numbersinbrackets indicatepercentages
ESGroup BLGroup
Gender
male 21 15
female 2 8
Age(years)
mean±standarddeviation 49.3±10.7 49.1±13.2
range 32–65 21–78
median 50 50
Etiology
alcohol 12(52.2) 10(43.5) hepatitisB 3(13.0) 1(4.3) hepatitisC 6(26.1) 8(34.9) others 2(8.7) 4(17.4) Child
A 8(34.8) 9(39.1)
B 12(52.2) 10(43.5)
C 3(13.0) 4(17.4)
Previousvaricealbleeding
yes 9(39.1) 12(52.2)
no 14(60.9) 11(47.8)
TABLE2–Eradication(intentiontotreat)andvaricealrecurrencein bothgroups
Group1 n(%)
Group2 n(%)
Total n(%)
Eradication
yes 18(78.3) 17(73.9) 35(76.1) no 5(21.7) 6(26.1) 11(23.9) Recurrence
werefollowed-up.Onepatientdiedandothertwoabandoned thestudy.Varicealrecurrencewasobservedin6/14(42.9%) patients.Nosignificantdifferencewasfound(P=0.45).
AllpatientsdevelopedulcersafterESand19/23(82.6%)of patientsintheBLgrouphadsuchcomplication.Nosignificant differencewasobserved.Althoughulcerdepthevaluationis very subjective, deep ulcers were more frequent in the ES group(P=0.001).
Bleedingwasobservedin8/23patients(34.8%)treated withESandin2/23(8.7%)treatedwithBL(P=0.03).The differencebetweenbothgroupswasestimatedin26.1%± 11.5%(CI95%:3.5%-48.7%).Whenvaricealbleedingand ulcerbleedingwereanalyzedseparatelytherewasnodifference betweengroups(P=0.40).
Mortality in both groups was similar (P = 0.7) with five (21.7%)andthree(13%)deathsrespectivelyintheESandBL group.Table3showsthattherewasnodifferenceinmortality associatedornottoendoscopictreatment(P=0.9).
ThethreedeathsintheESgroupweresecondarytobleeding inesophagealulcerswithin7daysafterinjection.Theotherdeaths wereduetoappendicitis(one)andhepaticfailure(one)after varicealeradication.IntheBLgroup,twodeathsweresecondary to bleeding esophageal ulcers after endoscopic procedures. Theotherdeathwasduetoliverfailure,withnorelationtothe endoscopictreatmentandoccurredaftereradication.
Dysphagiaandretrosternalpainresolvedspontaneously. Even in patients with severe and prolonged dysphagia no stenosis was seen. Retrosternal pain was more frequent in patientsundergoingESwhencomparedwithBL(P=0.03). Nodifferencewasobservedregardingdysphagia.
DISCUSSION
Numeroussclerosantshavebeenusedtoperformendoscopic sclerotherapy: polidocanol (1% to 3%), ethanolamine oleate (2,5%to5%),sodiumtetradecylsulfate(1%to2%),sodium morrhuate(5%),ethanol,hypertonicglucose,phenol(3%),and associationsofthem(9,17).Noneoftheseagentshasprovedtobe
betterthantheothers(31).SARINetal.(28)havecomparedabsolute
alcohol with 50% alcohol and showed that varices could be eradicatedinfewersessionsusingabsolutealcohol.Withthis
inmindwedecidedtocompareaverycheaptreatment(ESwith absolutealcohol)withthecurrentgoldstandard(endoscopic BL).Inthisrandomizedprospectivestudy46cirrhoticpatients weredividedintotwogroups(23patientsineachgroup).Seven patients(15.2%)hadadvancedliverdisease(ChildC).
Ourgrouphasstudiedtheprevalenceofbacteriainpatients withschistosomiasisafterESandBLandfoundsimilarresults inbothgroups.Inpatientswithlargevarices,BLmightbea betteroptionastheneedofinjectinglargeamountsofsclerosants mightraisecomplicationrates(24).
A very important point in EV treatment is the interval between endoscopic sessions. In this study, whenever we encounteredesophagealulcersthetherapeuticsessionswere postponed.SARINetal.(27)havesuggestednottopostponethe
treatment;theyjustavoidedinjectingalcoholinulceratedareas. BARONCINIetal.(1)waited7daysbetweenBLsessions.After
thefirst10patientstheydecidedfora14-dayintervaldueto pseudopolypformationcausedbytherings.Theysuggested agreaterriskofseverebleedinginthesepatients.
Asinnumerousstudies(12,15,19,40)includingours(24)although
ESandBLareequallyefficientineradicatingvarices,fewer sessions are necessary with BL.Variceal eradication was achievedin78.3%ofpatientstreatedwithESand73.9%in theBLgroup.Meannumberofeffectivesessions(excluding sessionswhichwerepostponed)was4.73±3.04inESgroup and2.91±2.04intheBLgroup(P=0.02).
After eradication with conventional ES, variceal recurrenceisseenin22%to58%ofpatientsafter2years offollow-up(11).Availableliteraturesuggeststhatvariceal
recurrenceisgreaterinpatientstreatedwithBL(8,13,37).Infour
studies(1,10,12,33)recurrencerangedbetween30%and70%of
patientsafter12to18monthsoffollow-up.Patientswith para-esophagealvaricesgreaterthan5mmindiameterhave higherchancesofrecurrence(14,16).Inourstudy,recurrence
wasobservedin26.7%ofpatientsintheESgroupandin 42.9%intheBLgroup,withoutsignificantdifference(P= 0.45).Samplesizeandthelengthoffollow-upareimportant factorsintheseresults.
DelaPEÑAetal.(8)haveshownvaricealrecurrencein23%
ofpatientstreatedwithESandin47%ofpatientstreatedwith BL1yearaftereradication.After3years,recurrencewas55% inthefirstgroupand92%inthesecond(P=0.003).
In1997,SARINetal.(33)comparedESwithabsolutealcohol
andBL(singlesession)andobserveda10.4%stenosisratein theESgroupcomparedtononeintheBLgroup.Wehavenot seenanycasesofstenosisnorperforation.Thelackofstenosis might be explained by the criterious intravariceal injection (maximum4mL)aswellasthepostponingofsessionswhen ulcerswherepresent.
Ethanolhasnotbeenextensivelystudiedandmostpapers come from Italy, India and Brazil(20, 22, 26, 29).Among all
sclerosantsavailable,absolutealcoholistheleastexpensive although it has been associated with deep esophageal ulcers,stenosisandhigherriskofre-bleeding(2, 6, 22).Ithas
beenshownthatintravaricealinjectionofsmallamountsof ethanol is effective in eradicating gastric and esophageal
TABLE3–Majorcomplicationsinbothgroups
Complications Group1n(%) Group2n(%) Totaln(%) P
Ulcers 23(100) 19(82.6) 42(91.3) NS shallow 4(17.4) 17(74.0) 21(45.6) 0.001 deep 19(82.6) 2(8.7) 21(45.6) 0.001 Hemorrhage 8(34.8) 2(8.7) 10(21.7) 0.032 variceal 5(21.7) -- 5(10.8) NS ulcer 3(13.0) 2(8.7) 5(10.8) NS Death 5(21.7) 3(13.0) 8(17.3) NS related 3(13.0) 2(8.7) 5(10.8) NS non-related 2(8.7) 1(4.3) 3(6.5) NS
variceswithfewcomplications(32, 29).Wemightsuggestthat
complications observed with ethanol might be related to sclerosantadministrationtechnique.
MEIRELLES-SANTOSetal.(20)haverecentlypublisheda
studyconductedinBrazilincluding157patientscomparingES witheitherethanolamineorabsolutealcohol.Thisstudydiffers fromoursas30%oftheirpatientshadschistosomiasis.Mean numberofsessionsnecessarytoeradicateEVwas5.4and5.9in thealcoholandethanolaminegroups,respectively.Eradication waspossiblein91%and88.7%ofpatients,respectivelywith alcoholandethanolamine.Nodifferenceswereseenregarding complication and mortality.The authors concluded that ES withalcoholwasaseffectiveaswith5%ethanolamine.They questioned if the complications observed by others were not relatedtotheincorrectuseofalcohol.
Regarding esophageal ulcers, we have observed 19 cases (82.6%)ofdeepulcersintheESgroupand17cases(74%)of shallowulcersintheBLgroup.DuringBL,deepulcersarenot commonbecausesuctionisnotdeepenough(25).
Inourpatientsweobservedeightcasesofbleeding(34.8%) intheESgroupandtwo(8.7%)intheBLgroup(P=0.032).The estimateddifferenceis26.1%±11.5%(95%CI:3.5%-48.7%). Bleedingsecondarytoulcersresultingindeathwasseeninthree patientsintheESgroupandintwointheBLgroup.
Althoughwehaddeeperulcersandmorebleedingepisodes in the ES group, mortality was not influenced by these two variables. Death was seen in five patients (21.7%) in the ES groupandinthree(13.0%)intheBLgroup,withoutsignificant difference.In1997,SARINetal.(33)comparedESwithabsolute
alcoholandBLin95patientsandobservedthreedeathsinboth ESandBLgroups.SHAFQATetal.(35)inasimilarstudyusing
75%alcoholobserveddeathin21%ofpatientsintheESgroup and11%intheBLgroup.
Retrosternalpainanddysphagiawereconsideredminor complications.Retrosternalpainwasseenin52.2%ofpatients intheESgroupand21.7%intheBLgroup(P=0.03).The lowrateofabandonintheESgroupsupportstheclinical irrelevanceofthiscomplication.
OurresultsallowustoconcludethatESwithabsolutealcohol andBLareequallyeffectiveineradicatingesophagealvarices. ESisassociatedwithhigherratesofbleeding,deeperulcersand retrosternalpain.Mortalityandvaricealrecurrencearesimilar.
ACKNOWLEDGEMENT
ThisstudywaspartiallysupportedbyagrantfromFAPESP (“Fundação deAmparo à Pesquisa do Estado de São Paulo”) process#98/15584-6.
FerrariAP,PauloGA,MacedoCMF,AraújoI,DellaLibera,JrE.Eficáciadainjeçãodeálcoolabsolutocomparadacomligaduraelásticana erradicaçãodevarizesdeesôfago.ArqGastroenterol2004;42(2):72-6.
RESUMO–Racional-Escleroterapiaendoscópicatemindicaçãoabsolutanotratamentodasvarizesdeesôfago.Ressangramentoécomum duranteoperíododetratamento,antesqueasvarizessejamerradicadas.Objetivo-Compararduastécnicasdeerradicaçãoendoscópicade varizesdeesôfago:escleroterapiacomálcoolabsolutoeligaduraelástica.PacienteseMétodo-Quarentaeseispacientescomcirrosehepática evarizesdeesôfagoforamprospectivamenterandomizadosemdoisgruposdetratamento:escleroterapiaendoscópicacomálcoolabsoluto eligaduraelástica.Ospacientesforamincluídosnoestudosetivessemvarizesdegrossocalibrecomsinaisdealtoriscodesangramento. ConsentimentoinformadoporescritofoiobtidodecadapacienteeoestudofoiaprovadopeloComitêdeÉticadainstituiçãoondeoestudo foirealizado.Apósaerradicação,todosospacientesforamseguidosdurante1anoparaavaliarataxaderessangramentoearecidivadas varizes.Resultados-Ambososgruposforamparecidosexcetonoqueserefereaosexomasculino,maiscomumnogrupodaescleroterapia. Nãohouvediferençaestatisticamentesignificanteemrelaçãoaerradicaçãodasvarizes(78,3%nogrupodaescleroterapiavs.73,9%no grupodaligadura),recidiva(26,7%vs.42,9%,respectivamente)emortalidaderelacionadaaqualquercausa(21,7%vs.13,9%).Nogrupo daescleroterapiahouvenecessidadedemaiornúmerodesessõesparaobtençãodaerradicaçãocompletadasvarizes.Nestemesmogrupo observou-sealtataxaderessangramento(34,8%)epresençademaisúlcerasassociadascomdorretroesternallogoapósoprocedimento.Não houvediferençanamorbimortalidadeglobal.Conclusões-Otratamentocomligaduraelásticarequermenossessõesdoqueaescleroterapia comálcoolabsolutoparaerradicarasvarizesdeesôfago.Ambososmétodossãoigualmenteeficazes,acurtoprazo,noquedizrespeitoà taxadeerradicaçãoerecidivadasvarizes.
DESCRITORES–Varizesesofágicaegástricas,terapia,Escleroterapia,Ligadura.Hipertensão,portal.Hemorragiagastrointestinal.
REFERENCES
1. BaronciniD,MilandriGL,BorioniD,PiemonteseA,CennamoV,BilliP,DalMonte PP,D’ImperioN.Aprospectiverandomizedtrialofsclerotherapyversusligationin theelectivetreatmentofbleedingesophagealvarices.Endoscopy1997;29:235-40. 2. BinmoellerKF,DateS,SoehendraN.Treatmentofesophagogastricvarices:endoscopic,
radiological,andpharmacologicaloptions.Endoscopy1998;30:105-13.
3. Bodily KO, Fitz JG. Approach to the patient with suspected liver disease. In: GrendellJH,McQuaidKR,FriedmanSL,editors.Current-diagnosis&treatment ingastroenterology.London:PrenticeHallInternational;1996.p.461-74.
4. BurroughsAK,PatchD.Primarypreventionofbleedingfromesophagealvarices.N EnglJMed1999;340:1033-5.
5. CipollettaL,BiancoMA,RotondanoG,MarmoR,MeucciC,PiscopoR.Argon plasmacoagulationpreventsvaricealrecurrenceafterbandligationofesophageal varices:preliminaryresultsofaprospectiverandomizedtrial.GastrointestEndosc 2002;56:467-71.
6. deFrenchisR,PrimignaniM.Endoscopictretmentsforportalhypertension.Baillieres ClinGastroenterol1997;11:289-309.
7. deFranchisR,BanaresR,SilvainC.Emergencyendoscopystrategiesforimproved outcomes.ScandJGastroenterol1998(Suppl226):25-36.
8. delaPenaJ,RiveroM,SanchezE,FabregaE,CrespoJ,Pons-RomeroF.Variceal ligationcomparedwithendoscopicsclerotherapyforvaricealhemorrhage:prospective randomizedtrial.GastrointestEndosc1999;49(4Pt1):417-23.
9. EisenGM,BaronTH,DominitzJA,FaigelDO,GoldsteinJL,JohansonJF,MalleryJS, RaddawiHM,VargoJJ,WaringJP,FanelliRD,Wheeler-HarbaughJ.Theroleofendoscopic therapyinthemanagementofvaricealhemorrhage.GastrointestEndosc2002;56:618-20. 10. GotohY,IwakiriR,SakataY,KoyamaT,NodaT,MatsunagaC,OgataSI,IshibashiS,
SakataH,TsunadaS,FujimotoK.Evaluationofendoscopicvaricealligationinprophylactic therapyforbleedingofoesophagealvarices:aprospective,controlledtrialcomparedwith endoscopicinjectionsclerotherapy.JGastroenterolHepatol1999;14:241-4.
11. HashizumeM,OhtaM,UenoK,TanoueK,KitanoS,SugimachiK.Endoscopic ligationofesophagealvaricescomparedwithinjectionsclerotherapy:aprospective randomizedtrial.GastrointestEndosc1993;39:123-6.
12. HouMC,LinHC,KuoBI,ChenCH,LeeFY,LeeSD.Comparisonofendoscopic varicealinjectionsclerotherapyandligationforthetreatmentofesophagealvariceal hemorrhage:aprospectiverandomizedtrial.Hepatology1995;21:1517-22. 13. LaineL,el-NewihiHM,MigikovskyB,SloaneR,GarciaF.Endoscopicligation
comparedwithsclerotherapyforthetreatmentofbleedingesophagealvarices.Ann InternMed1993;119:1-7.
14. LeungVK, Sung JJ,AhujaAT,Tumala IE, LeeYT, Lau JY, Chung SC. Large paraesophagealvaricesonendosonographypredictrecurrenceofesophagealvarices andrebleeding.Gastroenterology1997;112:1811-6.
15. LoGH,LaiKH,ChengJS,HwuJH,ChangCF,ChenSM,ChiangHT.Aprospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophagealvarices.Hepatology1995;22:466-71.
16. LoGH,LaiKH,ChengJS,HuangRL,WangSJ,ChiangHT.Prevalenceofparaesophageal varicesandgastricvaricesinpatientsachievingvaricealobliterationbybandingligation andbyinjectionsclerotherapy.GastrointestEndosc1999;49(4Pt1):428-36. 17. LuketicVA,SanyalAJ.Esophagealvarices.I.Clinicalpresentation,medicaltherapy,
andendoscopictherapy.GastroenterolClinNorthAm2000;29:337-85.
18. Marrero JA, Scheiman JM. Prevention of recurrent variceal bleeding: as easy as A.P.C.?GastrointestEndosc2002;56:600-3.
19. MasciE,StiglianoR,MarianiA,BertoniG,BaronciniD,CennamoV,MichelettiG, CasettiT,Tansini P, Buscarini E, Ranzato R, Norberto L. Prospective multicenter randomizedtrialcomparingbandingligationwithsclerotherapyofesophagealvarices. Hepatogastroenterology1999;46:1769-73.
20. Meirelles-SantosJO,CarvalhoJrAF,Callejas-NetoF,MagnaLA,YamanakaA,ZeituneJM, BrandaliseNA,FerrazJG.Absoluteethanoland5%ethanolamineoleatearecomparable forsclerotherapyofesophagealvarices.GastrointestEndosc2000;51:573-6. 21. MemonMA,JonesWF.Injectiontherapyforvaricealbleeding.GastrointestEndosc
ClinNorthAm1999;9:231-52.
22. Paoluzi P, PietroiustiA, Ferrari S, Cappa M, PagnanelliA. Absolute alcohol in esophagealveinsclerosis.GastrointestEndosc1988;34:400-2.
23. RobertsLR,KamathPS.Pathophysiologyofvaricealbleeding.GastrointestEndosc ClinNorthAm1999;9:167-74.
24. RohrMRS,SiqueiraES,BrantCQ,MoraisM,LiberaED,FerrariAP.Prospectivestudy ofbacteremiarateafterelasticbandligationandsclerotherapyofesophagealvarices inpatientswithhepatosplenicschistosomiasis.GastrointestEndosc1997;46:321-3.
25. SaeedZA,MichaletzPA,WinchesterCB,WoodsKL,DixonWB,HieserMC,Gentry KR,RamirezFC.Endoscopicvaricealligationinpatientswhohavefailedendoscopic sclerotherapy.GastrointestEndosc1990;36:572-4.
26. SakaiP,BoaventuraS,CapacciML,MacedoTM,IshiokaSZ.Endoscopicsclerotherapy of bleeding esophageal varices.A comparative study of results in patients with schistosomiasisandcirrhosis.Endoscopy1988;20:134-6.
27. SarinSK,SachdevaGK,NandaR,VijJC,AnandBS.Endoscopicsclerotherapyusing absolutealcohol.Gut1985;26:120-4.
28. SarinSK,NandaR,SachdevG.Relativeefficacyandsafetyofabsolutealcoholand 50%alcoholasvaricealsclerosants.GastrointestEndosc1987;33:362-5. 29. Sarin SK, Nanda R, Sachdev G, Chari S,Anand BS, Broor SL. Intravariceal
versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut1987;28:657-62
30. SarinSK,MishraSP,SachdevGK,ThoratV,DalalL,BroorSL.Ethanolamineoleate versusabsolutealcoholasavaricealsclerosant:aprospective,randomized,controlled trial.AmJGastroenterol1988;83:526-30.
31. SarinSK,KumarA.Sclerosantsforvaricealsclerotherapy:acriticalappraisal.Am JGastroenterol1990;85:641-9.
32. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience.GastrointestEndosc1997;46:8-14.
33. SarinSK,GovilA,JainAK,GuptanRC,IssarSK,JainM,MurthyNS.Prospectiverandomized trialofendoscopicsclerotherapyversusvaricealbandligationforesophagealvarices:influence ongastropathy,gastricvaricesandvaricealrecurrence.JHepatol1997;26:826-32. 34. SeewaldS,SeitzU,YangAM,SoehendraN.Varicealbleedingandportalhypertension:
stillatherapeuticchallenge?Endoscopy2001;33:126-39.
35. ShafqatF,KhanAA,AlamA,Arshad,ButtK,ShahSW,NaqviAB.Bandligationvs endoscopicsclerotherapyinesophagealvarices:aprospectiverandomizedcomparison. JPakMedAssoc1998;48:192-6.
36. Shahi HM, Sarin SK. Prevention of first variceal bleed: an appraisal of current therapies.AmJGastroenterol1998;93:2348-58.
37. SvobodaP,KantorovaI,OchmannJ,KozumplikL,MarsovaJ.Aprospectiverandomized controlledtrialofsclerotherapyvsligationintheprophylactictreatmentofhigh-risk esophagealvarices.SurgEndosc1999;13:580-4.
38. TaitIS,KrigeJE,TerblancheJ.Endoscopicbandligationofoesophagealvarices.Br JSurg1999;86:437-46.
39. VanStiegmannG,CambreT,SunJH.Anewendoscopicelasticbandligatingdevice. GastrointestEndosc1986;32:230-3.
40. VanStiegmannG,IsshiK.Elasticbandligationforbleedingesophagogastricvarices. Hepatogastroenterology1997;44:620-4.